Preface |
|
xxi | |
Preface to the second edition |
|
xxii | |
Preface to the third edition |
|
xxii | |
Text organization |
|
xxiii | |
Specific features of this text designed to aid instructors and students in pursuing topics in greater depth |
|
xxvi | |
Depth of coverage |
|
xxvi | |
Sources for further study |
|
xxvi | |
The Internet |
|
xxvii | |
Chapter outlines |
|
xxvii | |
Case studies |
|
xxvii | |
Review material |
|
xxvii | |
Glossary |
|
xxvii | |
Acknowledgments |
|
xxix | |
|
PART I VIROLOGY AND VIRAL DISEASE |
|
|
1 | (62) |
|
Introduction - The Impact of Viruses on Our View of Life |
|
|
3 | (12) |
|
|
3 | (11) |
|
The effect of virus infections on the host organism and populations - viral pathogenesis, virulence, and epidemiology |
|
|
4 | (2) |
|
The interaction between viruses and their hosts |
|
|
6 | (1) |
|
|
7 | (1) |
|
Examples of the impact of viral disease on human history |
|
|
8 | (1) |
|
Examples of the evolutionary impact of the virus-host interaction |
|
|
9 | (1) |
|
|
9 | (3) |
|
Viruses have a constructive as well as destructive impact on society |
|
|
12 | (1) |
|
Viruses are not the smallest self-replicating pathogens |
|
|
13 | (1) |
|
|
14 | (1) |
|
An Outline of Virus Replication and Viral Pathogenesis |
|
|
15 | (12) |
|
|
15 | (4) |
|
Stages of virus replication in the cell |
|
|
17 | (2) |
|
Pathogenesis of viral infection |
|
|
19 | (6) |
|
Stages of virus-induced pathology |
|
|
19 | (1) |
|
Initial stages of infection - entry of the virus into the host |
|
|
20 | (1) |
|
The incubation period and spread of virus through the host |
|
|
21 | (2) |
|
Multiplication of virus to high levels - occurrence of disease symptoms |
|
|
23 | (1) |
|
The later stages of infection - the immune response |
|
|
24 | (1) |
|
The later stages of infection - virus spread to the next individual |
|
|
24 | (1) |
|
The later stages of infection - fate of the host |
|
|
24 | (1) |
|
|
25 | (2) |
|
Virus Disease in Populations and Individual Animals |
|
|
27 | (14) |
|
The nature of virus reservoirs |
|
|
27 | (3) |
|
Some viruses with human reservoirs |
|
|
28 | (2) |
|
Some viruses with vertebrate reservoirs |
|
|
30 | (1) |
|
|
30 | (4) |
|
Viral epidemiology in small and large populations |
|
|
30 | (3) |
|
Factors affecting the control of viral disease in populations |
|
|
33 | (1) |
|
Animal models to study viral pathogenesis |
|
|
34 | (6) |
|
A mouse model for studying poxvirus infection and spread |
|
|
35 | (2) |
|
Rabies: where is the virus during its long incubation period? |
|
|
37 | (1) |
|
Herpes simplex virus latency |
|
|
37 | (2) |
|
|
39 | (1) |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
40 | (1) |
|
Patterns of Some Viral Diseases of Humans |
|
|
41 | (22) |
|
The dynamics of human-virus interactions |
|
|
42 | (7) |
|
The stable association of viruses with their natural host places specific constraints on the nature of viral disease and mode of persistence |
|
|
42 | (2) |
|
Classification of human disease-causing viruses according to virus-host dynamics |
|
|
44 | (1) |
|
Viral diseases leading to persistence of the virus in the host are generally associated with viruses having long associations with human populations |
|
|
44 | (4) |
|
Viral diseases associated with acute, severe infection are suggestive of zoonoses |
|
|
48 | (1) |
|
Patterns of specific viral diseases of humans |
|
|
49 | (5) |
|
Acute infections followed by virus clearing |
|
|
49 | (1) |
|
Colds and respiratory infections |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
Infection of an ``accidental'' target tissue leading to permanent damage despite efficient clearing |
|
|
50 | (1) |
|
Persistent viral infections |
|
|
50 | (1) |
|
Papilloma and polyomavirus infections |
|
|
50 | (2) |
|
Herpesvirus infections and latency |
|
|
52 | (1) |
|
Other complications arising from persistent infections |
|
|
52 | (1) |
|
Viral and subviral diseases with long incubation periods |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
54 | (1) |
|
Some viral infections targeting specific organ systems |
|
|
54 | (4) |
|
Viral infections of nerve tissue |
|
|
54 | (1) |
|
Examples of viral encephalitis with grave prognosis |
|
|
55 | (1) |
|
|
55 | (1) |
|
|
55 | (1) |
|
Viral encephalitis with favorable prognosis for recovery |
|
|
56 | (1) |
|
Viral infections of the liver (viral hepatitis) |
|
|
56 | (1) |
|
|
57 | (1) |
|
|
57 | (1) |
|
|
57 | (1) |
|
|
57 | (1) |
|
|
58 | (1) |
|
|
58 | (1) |
|
|
59 | (2) |
|
Additional Reading for Part I |
|
|
61 | (2) |
|
PART II BASIC PROPERTIES OF VIRUSES AND VIRUS-CELL INTERACTION |
|
|
63 | (82) |
|
Virus Structure and Classification |
|
|
65 | (14) |
|
|
65 | (7) |
|
|
69 | (1) |
|
|
69 | (3) |
|
|
72 | (1) |
|
|
72 | (5) |
|
The Baltimore scheme of virus classification |
|
|
75 | (1) |
|
Disease-based classification schemes for viruses |
|
|
75 | (2) |
|
|
77 | (1) |
|
|
78 | (1) |
|
The Beginning and End of the Virus Replication Cycle |
|
|
79 | (18) |
|
Outline of the virus replication cycle |
|
|
79 | (1) |
|
|
80 | (9) |
|
Animal virus entry into cells - the role of the cellular receptor |
|
|
80 | (3) |
|
Mechanisms of entry of nonenveloped viruses |
|
|
83 | (1) |
|
Entry of enveloped viruses |
|
|
84 | (1) |
|
Entry of virus into plant cells |
|
|
85 | (2) |
|
Injection of bacteriophage DNA into Escherichia coli |
|
|
87 | (2) |
|
Nonspecific methods of introducing viral genomes into cells |
|
|
89 | (1) |
|
Late events in viral infection: capsid assembly and virion release |
|
|
89 | (7) |
|
Assembly of helical capsids |
|
|
89 | (3) |
|
Assembly of icosahedral capsids |
|
|
92 | (1) |
|
Generation of the virion envelope and egress of the enveloped virion |
|
|
93 | (3) |
|
|
96 | (1) |
|
Host Immune Response to Viral Infection - The Nature of the Vertebrate Immune Response |
|
|
97 | (22) |
|
The innate immune response - early defense against pathogens |
|
|
98 | (2) |
|
|
99 | (1) |
|
|
99 | (1) |
|
The adaptive immune response and the lymphatic system |
|
|
100 | (8) |
|
Two pathways of helper T response - the fork in the road |
|
|
101 | (1) |
|
The immunological structure of a protein |
|
|
102 | (2) |
|
Role of the antigen-presenting cell in initiation of the immune response |
|
|
104 | (3) |
|
Clonal selection of immune reactive lymphocytes |
|
|
107 | (1) |
|
|
108 | (1) |
|
Complement-mediated cell lysis |
|
|
108 | (1) |
|
Control and dysfunction of immunity |
|
|
108 | (4) |
|
Specific viral responses to host immunity |
|
|
109 | (1) |
|
Passive evasion of immunity - antigenic drift |
|
|
110 | (1) |
|
Passive evasion of immunity - internal sanctuaries for infectious virus |
|
|
110 | (1) |
|
Passive evasion of immunity - immune tolerance |
|
|
110 | (1) |
|
Active evasion of immunity - immunosuppression |
|
|
111 | (1) |
|
Active evasion of immunity - blockage of MHC antigen presentation |
|
|
111 | (1) |
|
Consequences of immune suppression to virus infections |
|
|
112 | (1) |
|
Measurement of the immune reaction |
|
|
112 | (5) |
|
Measurement of cell-mediated (T-cell) immunity |
|
|
112 | (1) |
|
Measurement of antiviral antibody |
|
|
112 | (1) |
|
Enzyme-linked immunosorbent assays (ELISAs) |
|
|
113 | (1) |
|
|
114 | (1) |
|
Inhibition of hemagglutination |
|
|
114 | (1) |
|
|
115 | (2) |
|
|
117 | (2) |
|
Strategies to Protect Against and Combat Viral Infection |
|
|
119 | (26) |
|
Vaccination - induction of immunity to prevent virus infection |
|
|
120 | (6) |
|
|
120 | (1) |
|
Smallpox and the history of vaccination |
|
|
120 | (2) |
|
How a vaccine is produced |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
123 | (1) |
|
Recombinant virus vaccines |
|
|
124 | (1) |
|
Capsid and subunit vaccines |
|
|
124 | (1) |
|
|
125 | (1) |
|
|
125 | (1) |
|
Problems with vaccine production and use |
|
|
125 | (1) |
|
Eukaryotic cell-based defenses against virus replication |
|
|
126 | (5) |
|
|
126 | (1) |
|
|
127 | (1) |
|
|
128 | (1) |
|
Measurement of interferon activity |
|
|
128 | (2) |
|
Other cellular defenses against viral infection |
|
|
130 | (1) |
|
|
130 | (1) |
|
Enzymatic modification of viral genomes |
|
|
131 | (1) |
|
|
131 | (1) |
|
Targeting antiviral drugs to specific features of the virus replication cycle |
|
|
131 | (4) |
|
Acyclovir and the herpesviruses |
|
|
132 | (1) |
|
Blocking influenza virus entry and virus maturation |
|
|
132 | (2) |
|
Chemotherapeutic approaches for HIV |
|
|
134 | (1) |
|
Multiple drug therapies to reduce or eliminate mutation to drug resistance |
|
|
134 | (1) |
|
|
135 | (1) |
|
Bacterial antiviral systems - restriction endonucleases |
|
|
135 | (1) |
|
|
136 | (3) |
|
|
139 | (4) |
|
Additional Reading for Part II |
|
|
143 | (2) |
|
PART III WORKING WITH VIRUS |
|
|
145 | (98) |
|
Visualization and Enumeration of Virus Particles |
|
|
147 | (8) |
|
Using the electron microscope to study and count viruses |
|
|
147 | (2) |
|
Counting (enumeration) of virions with the electron microscope |
|
|
149 | (2) |
|
Atomic force microscopy - a rapid and sensitive method for visualization of viruses and infected cells, potentially in real time |
|
|
151 | (1) |
|
Indirect methods for ``counting'' virus particles |
|
|
152 | (2) |
|
|
154 | (1) |
|
Replicating and Measuring Biological Activity of Viruses |
|
|
155 | (18) |
|
|
156 | (1) |
|
Maintenance of bacterial cells |
|
|
156 | (1) |
|
|
156 | (1) |
|
Culture of animal and human cells |
|
|
157 | (1) |
|
Maintenance of cells in culture |
|
|
157 | (1) |
|
|
157 | (2) |
|
Loss of contact inhibition of growth and immortalization of primary cells |
|
|
159 | (1) |
|
The outcome of virus infection in cells |
|
|
160 | (4) |
|
|
160 | (2) |
|
Fate of the cell following virus infection |
|
|
162 | (1) |
|
Cell-mediated maintenance of the intra- and intercellular environment |
|
|
162 | (1) |
|
Virus-mediated cytopathology - changes in the physical appearance of cells |
|
|
163 | (1) |
|
Virus-mediated cytopathology - changes in the biochemical properties of cells |
|
|
163 | (1) |
|
Measurement of the biological activity of viruses |
|
|
164 | (6) |
|
Quantitative measure of infectious centers |
|
|
164 | (1) |
|
|
164 | (1) |
|
Generation of transformed cell foci |
|
|
165 | (1) |
|
Use of virus titers to quantitatively control infection conditions |
|
|
166 | (1) |
|
Examples of plaque assays |
|
|
167 | (1) |
|
Statistical analysis of infection |
|
|
168 | (1) |
|
Dilution endpoint methods |
|
|
169 | (1) |
|
The relation between dilution endpoint and infectious units of virus |
|
|
169 | (1) |
|
|
170 | (3) |
|
Physical and Chemical Manipulation of the Structural Components of Viruses |
|
|
173 | (20) |
|
Viral structural proteins |
|
|
173 | (6) |
|
Isolation of structural proteins of the virus |
|
|
174 | (2) |
|
Size fractionation of viral structural proteins |
|
|
176 | (1) |
|
Determining the stoichiometry of capsid proteins |
|
|
177 | (1) |
|
The poliovirus capsid - a virion with equimolar capsid proteins |
|
|
178 | (1) |
|
Analysis of viral capsids chat do not contain equimolar numbers of proteins |
|
|
179 | (1) |
|
Characterizing viral genomes |
|
|
179 | (12) |
|
Sequence analysis of viral genomes |
|
|
180 | (4) |
|
Measuring the size of viral genomes |
|
|
184 | (1) |
|
Direct measure of DNA genome lengths in the electron microscope |
|
|
185 | (1) |
|
Rate zonal sedimentation and gel electrophoresis for measuring viral genome size |
|
|
185 | (2) |
|
The polymerase chain reaction - detection and characterization of extremely small quantities of viral genomes or transcripts |
|
|
187 | (2) |
|
Real time PCR for precise quantitative measures of viral DNA |
|
|
189 | (1) |
|
|
190 | (1) |
|
PCR as an epidemiological tool |
|
|
190 | (1) |
|
|
191 | (2) |
|
Characterization of Viral Products Expressed in the Infected Cell |
|
|
193 | (20) |
|
Characterization of viral proteins in the infected cell |
|
|
193 | (12) |
|
Pulse labeling of viral proteins at different times following infection |
|
|
194 | (1) |
|
Use of immune reagents for study of viral proteins |
|
|
195 | (1) |
|
|
196 | (2) |
|
Detection of viral proteins using immunofluorescence |
|
|
198 | (3) |
|
Related methods for detecting antibodies bound to antigens |
|
|
201 | (4) |
|
Detecting and characterizing viral nucleic acids in infected cells |
|
|
205 | (5) |
|
Detecting the synthesis of viral genomes |
|
|
205 | (1) |
|
Characterization of viral mRNA expressed during infection |
|
|
205 | (2) |
|
|
207 | (2) |
|
Further characterization of specific viral mRNA molecules |
|
|
209 | (1) |
|
Use of microarray technology for getting a complete picture of the events occurring in the infected cell |
|
|
210 | (2) |
|
|
212 | (1) |
|
Viruses Use Cellular Processes to Express Their Genetic Information |
|
|
213 | (30) |
|
Prokaryotic DNA replication is an accurate enzymatic model for the process generally |
|
|
215 | (1) |
|
The replication of eukaryotic DNA |
|
|
216 | (1) |
|
The replication of viral DNA |
|
|
217 | (1) |
|
The effect of virus infection on host DNA replication |
|
|
217 | (1) |
|
|
217 | (2) |
|
Prokaryotic transcription |
|
|
219 | (1) |
|
Prokaryotic RNA polymerase |
|
|
219 | (1) |
|
The prokaryotic promoter and initiation of transcription |
|
|
220 | (1) |
|
Control of prokaryotic initiation of transcription |
|
|
220 | (1) |
|
Termination of prokaryotic transcription |
|
|
221 | (1) |
|
|
221 | (1) |
|
The promoter and initiation of transcription |
|
|
221 | (2) |
|
Control of initiation of eukaryotic transcription |
|
|
223 | (1) |
|
Processing of precursor mRNA |
|
|
224 | (2) |
|
Visualization and location of splices in eukaryotic transcripts |
|
|
226 | (5) |
|
Posttranscriptional regulation of eukaryotic mRNA function |
|
|
231 | (1) |
|
Virus-induced changes in transcription and posttranscriptional processing |
|
|
232 | (1) |
|
The mechanism of protein synthesis |
|
|
232 | (1) |
|
|
233 | (1) |
|
|
234 | (2) |
|
Virus-induced changes in translation |
|
|
236 | (1) |
|
|
236 | (3) |
|
|
239 | (2) |
|
Additional Reading for Part III |
|
|
241 | (2) |
|
PART IV REPLICATION PATTERNS OF SPECIFIC VIRUSES |
|
|
243 | (190) |
|
Replication of Positive-sense RNA Viruses |
|
|
245 | (28) |
|
RNA viruses - general considerations |
|
|
246 | (2) |
|
A general picture of RNA-directed RNA replication |
|
|
246 | (2) |
|
Replication of positive-sense RNA viruses whose genomes are translated as the first step in gene expression |
|
|
248 | (1) |
|
Positive-sense RNA viruses encoding a single large open reading frame |
|
|
249 | (8) |
|
|
249 | (1) |
|
The poliovirus genetic map and expression of poliovirus proteins |
|
|
249 | (3) |
|
The poliovirus replication cycle |
|
|
252 | (2) |
|
Picornavirus cytopathology and disease |
|
|
254 | (2) |
|
|
256 | (1) |
|
Positive-sense RNA viruses encoding more than one translational reading frame |
|
|
257 | (10) |
|
Two viral mRNAs are produced in different amounts during togavirus infections |
|
|
258 | (1) |
|
|
258 | (1) |
|
The virus replication cycle |
|
|
258 | (4) |
|
Togavirus cytopathology and disease |
|
|
262 | (1) |
|
A somewhat more complex scenario of multiple translational reading frames and subgenomic mRNA expression: coronavirus replication |
|
|
263 | (1) |
|
|
264 | (2) |
|
Cytopathology and disease caused by coronaviruses |
|
|
266 | (1) |
|
Replication of plant viruses with RNA genomes |
|
|
267 | (2) |
|
Viruses with one genome segment |
|
|
268 | (1) |
|
Viruses with two genome segments |
|
|
268 | (1) |
|
Viruses with three genome segments |
|
|
269 | (1) |
|
Replication of bacteriophage with RNA genomes |
|
|
269 | (3) |
|
Regulated translation of bacteriophage mRNA |
|
|
269 | (3) |
|
|
272 | (1) |
|
Replication Strategies of RNA Viruses Requiring RNA-directed mRNA Transcription as the First Step in Viral Gene Expression |
|
|
273 | (30) |
|
Replication of negative-sense RNA viruses with a monopartite genome |
|
|
275 | (8) |
|
Replication of vesicular stomatitis virus - a model for Mononegavirales |
|
|
275 | (1) |
|
Vesicular stomatitis virus virion and genome |
|
|
275 | (1) |
|
Generation, capping, and polyadenylation of mRNA |
|
|
276 | (2) |
|
Generation of new negative-sense virion RNA |
|
|
278 | (1) |
|
Mechanism of host shutoff by vesicular stomatitis virus |
|
|
279 | (1) |
|
Cytopathology and diseases caused by rhabdoviruses |
|
|
280 | (1) |
|
|
280 | (1) |
|
Pathogenesis of paramyxoviruses |
|
|
280 | (2) |
|
Filoviruses and their pathogenesis |
|
|
282 | (1) |
|
|
282 | (1) |
|
Influenza viruses - negative-sense RNA viruses with a multipartite genome |
|
|
283 | (5) |
|
Involvement of the nucleus in flu virus replication |
|
|
284 | (1) |
|
Generation of new flu nucleocapsids and maturation of the virus |
|
|
285 | (1) |
|
|
285 | (3) |
|
Other negative-sense RNA viruses with multipartite genomes |
|
|
288 | (4) |
|
|
288 | (1) |
|
Virus structure and replication |
|
|
288 | (3) |
|
|
291 | (1) |
|
|
291 | (1) |
|
|
292 | (1) |
|
|
292 | (1) |
|
Viruses with double-stranded RNA genomes |
|
|
292 | (3) |
|
|
292 | (2) |
|
Reovirus replication cycle |
|
|
294 | (1) |
|
|
295 | (1) |
|
|
295 | (6) |
|
|
296 | (1) |
|
|
297 | (1) |
|
|
298 | (3) |
|
|
301 | (2) |
|
Replication Strategies of Small and Medium-Sized DNA Viruses |
|
|
303 | (28) |
|
DNA viruses express genetic information and replicate their genomes in similar, yet distinct, ways |
|
|
304 | (1) |
|
|
305 | (14) |
|
Replication of SV40 virus - the model polyomavirus |
|
|
305 | (4) |
|
The SV40 genome and genetic map |
|
|
309 | (1) |
|
Productive infection by SV40 |
|
|
310 | (2) |
|
Abortive infection of cells nonpermissive for SV40 replication |
|
|
312 | (2) |
|
Replication of papillomaviruses |
|
|
314 | (2) |
|
|
316 | (1) |
|
Virus replication and cytopathology |
|
|
316 | (3) |
|
Replication of adenoviruses |
|
|
319 | (4) |
|
Physical properties of adenovirus |
|
|
319 | (1) |
|
|
319 | (1) |
|
|
319 | (1) |
|
The adenovirus replication cycle |
|
|
319 | (1) |
|
|
319 | (2) |
|
Adenovirus DNA replication |
|
|
321 | (1) |
|
|
321 | (1) |
|
VA transcription and cytopathology |
|
|
321 | (2) |
|
Transformation of nonpermissive cells by adenovirus |
|
|
323 | (1) |
|
Replication of some single-stranded DNA viruses |
|
|
323 | (5) |
|
Replication of parvoviruses |
|
|
323 | (1) |
|
Dependovirus DNA integrates in a specific site in the host cell genome |
|
|
324 | (1) |
|
Parvoviruses have potentially exploitable therapeutic applications |
|
|
325 | (1) |
|
DNA viruses infecting vascular plants |
|
|
325 | (1) |
|
|
325 | (1) |
|
Single-stranded DNA bacteriophage ΦX174 packages its genes very compactly |
|
|
326 | (2) |
|
|
328 | (3) |
|
Replication of Some Nuclear-Replicating Eukaryotic DNA Viruses with Large Genomes |
|
|
331 | (28) |
|
Herpesvirus replication and latency |
|
|
332 | (23) |
|
The herpesviruses as a group |
|
|
332 | (1) |
|
Genetic complexity of herpesviruses |
|
|
333 | (1) |
|
Common features of herpesvirus replication in the host |
|
|
333 | (1) |
|
The replication of the prototypical alpha-herpesvirus -- HSV |
|
|
334 | (1) |
|
|
334 | (1) |
|
|
334 | (4) |
|
|
338 | (9) |
|
|
347 | (1) |
|
HSV transcription during latency and reactivation |
|
|
348 | (2) |
|
How do LAT and other specific HSV genes function -- may be to accommodate reactivation? |
|
|
350 | (1) |
|
EBV latent infection of lymphocytes, a different set of problems and answers |
|
|
351 | (3) |
|
Pathology of herpesvirus infections |
|
|
354 | (1) |
|
Herpesviruses as infectious co-carcinogens |
|
|
354 | (1) |
|
Baculovirus, an insect virus with important practical uses in molecular biology |
|
|
355 | (2) |
|
|
355 | (1) |
|
Viral gene expression and genome replication |
|
|
356 | (1) |
|
|
356 | (1) |
|
Importance of baculoviruses in biotechnology |
|
|
356 | (1) |
|
|
357 | (2) |
|
Replication of Cytoplasmic DNA Viruses and ``Large'' Bacteriophages |
|
|
359 | (22) |
|
Poxviruses -- DNA viruses that replicate in the cytoplasm of eukaryotic cells |
|
|
360 | (5) |
|
The pox virion is complex and contains virus-coded transcription enzymes |
|
|
360 | (1) |
|
The poxvirus replication cycle |
|
|
361 | (2) |
|
|
363 | (1) |
|
|
363 | (1) |
|
Intermediate and late stages of replication |
|
|
363 | (1) |
|
Pathogenesis and history of poxvirus infections |
|
|
364 | (1) |
|
Is smallpox virus a potential biological terror weapon? |
|
|
364 | (1) |
|
Replication of ``large'' DNA-containing bacteriophages |
|
|
365 | (11) |
|
Components of large DNA-containing phage virions |
|
|
365 | (2) |
|
|
367 | (1) |
|
|
367 | (1) |
|
Phage-controlled transcription |
|
|
367 | (1) |
|
The practical value of T7 |
|
|
367 | (1) |
|
T4 bacteriophage: the basic model for all DNA viruses |
|
|
367 | (1) |
|
|
368 | (1) |
|
Regulated gene expression during T4 replication |
|
|
369 | (1) |
|
Capsid maturation and release |
|
|
370 | (1) |
|
Replication of phage λ: a ``simple'' model for latency and reactivation |
|
|
370 | (2) |
|
|
372 | (1) |
|
Phage λ gene expression immediately after infection |
|
|
372 | (3) |
|
Biochemistry of the decision between lytic and lysogenic infection in E. coli |
|
|
375 | (1) |
|
A group of algal viruses shares features of its genome structure with poxviruses and bacteriophages |
|
|
376 | (1) |
|
|
377 | (4) |
|
Retroviruses: Converting RNA to DNA |
|
|
381 | (18) |
|
Retrovirus families and their strategies of replication |
|
|
382 | (10) |
|
The molecular biology of retrovirus |
|
|
383 | (1) |
|
Retrovirus structural proteins |
|
|
383 | (1) |
|
|
384 | (2) |
|
Genetic maps of representative retroviruses |
|
|
386 | (1) |
|
Replication of retroviruses: an outline of the replication process |
|
|
386 | (1) |
|
|
386 | (3) |
|
Capsid assembly and maturation |
|
|
389 | (1) |
|
Action of reverse transcriptase and RNase-H in synthesis of cDNA |
|
|
389 | (2) |
|
Virus gene expression, assembly, and maturation |
|
|
391 | (1) |
|
Transcription and translation of viral mRNA |
|
|
391 | (1) |
|
Capsid assembly and morphogenesis |
|
|
391 | (1) |
|
Mechanisms of retrovirus transformation |
|
|
392 | (3) |
|
Transformation through the action of a viral oncogene -- a subverted cellular growth control gene |
|
|
392 | (1) |
|
Oncornavirus alteration of normal cellular transcriptional control of growth regulation |
|
|
393 | (2) |
|
Oncornavirus transformation by growth stimulation of neighboring cells |
|
|
395 | (1) |
|
Cellular genetic elements related to retroviruses |
|
|
395 | (2) |
|
|
396 | (1) |
|
The relationship between transposable elements and viruses |
|
|
397 | (1) |
|
|
397 | (2) |
|
Human Immunodeficiency Virus Type 1 (HIV-1) and Related Lentiviruses |
|
|
399 | (14) |
|
HIV-1 and related lentiviruses |
|
|
399 | (1) |
|
The origin of HIV-1 and AIDS |
|
|
399 | (1) |
|
HIV-1 and lentiviral replication |
|
|
400 | (6) |
|
Destruction of the immune system by HIV-1 |
|
|
406 | (5) |
|
|
411 | (2) |
|
Hepadnaviruses: Variations on the Retrovirus Theme |
|
|
413 | (20) |
|
The virion and the viral genome |
|
|
413 | (2) |
|
The viral replication cycle |
|
|
415 | (1) |
|
The pathogenesis of hepatitis B virus |
|
|
415 | (1) |
|
A plant ``hepadnavirus'': cauliflower mosaic virus |
|
|
416 | (1) |
|
|
416 | (1) |
|
Viral gene expression and genome replication |
|
|
416 | (1) |
|
The evolutionary origin of hepadnaviruses |
|
|
417 | (2) |
|
|
419 | (2) |
|
|
421 | (8) |
|
Additional Reading for Part IV |
|
|
429 | (4) |
|
PART V VIRUSES: NEW APPROACHES AND NEW PROBLEMS |
|
|
433 | (68) |
|
The Molecular Genetics of Viruses |
|
|
435 | (28) |
|
Mutations in genes and resulting changes to proteins |
|
|
437 | (1) |
|
|
438 | (1) |
|
|
438 | (1) |
|
|
439 | (1) |
|
|
440 | (1) |
|
|
440 | (1) |
|
HSV thymidine kinase -- a portable selectable marker |
|
|
440 | (1) |
|
|
441 | (1) |
|
A tool kit for molecular virologists |
|
|
441 | (20) |
|
|
441 | (1) |
|
Locating sites of restriction endonuclease cleavage on the viral genome -- restriction mapping |
|
|
442 | (1) |
|
|
443 | (1) |
|
Cloning of fragments of viral genomes using bacterial plasmids |
|
|
444 | (5) |
|
|
449 | (2) |
|
Cloning single-stranded DNA with bacteriophage M13 |
|
|
451 | (1) |
|
|
451 | (2) |
|
RNA virus expression systems |
|
|
453 | (1) |
|
Defective virus particles |
|
|
454 | (1) |
|
Directed mutagenesis of viral genes |
|
|
454 | (2) |
|
Site-directed mutagenesis |
|
|
456 | (1) |
|
Generation of recombinant viruses |
|
|
456 | (2) |
|
Bacterial artificial chromosomes |
|
|
458 | (3) |
|
|
461 | (2) |
|
|
463 | (10) |
|
An introduction to the study of viral pathogenesis |
|
|
463 | (1) |
|
|
464 | (2) |
|
Choosing a model: natural host vs. surrogate models |
|
|
464 | (1) |
|
Development of new models: transgenic animals |
|
|
464 | (1) |
|
Hybrid models: the SCID-hu mouse |
|
|
464 | (1) |
|
Considerations regarding the humane use of animals |
|
|
465 | (1) |
|
Methods for the study of pathogenesis |
|
|
466 | (4) |
|
|
466 | (1) |
|
Analysis of viral spread within the host |
|
|
467 | (3) |
|
Resolving the infection to the level of single cells |
|
|
470 | (1) |
|
Characterization of the host response |
|
|
470 | (1) |
|
|
470 | (1) |
|
Use of transgenic mice to dissect critical components of the host immune response that modulate the viral infection |
|
|
471 | (1) |
|
|
471 | (2) |
|
Viral Bioinformatics and Beyond |
|
|
473 | (12) |
|
|
473 | (1) |
|
Bioinformatics and virology |
|
|
473 | (1) |
|
|
474 | (2) |
|
|
474 | (1) |
|
|
475 | (1) |
|
|
475 | (1) |
|
|
476 | (1) |
|
|
476 | (3) |
|
Similarity searching tools |
|
|
476 | (2) |
|
Protein functional analysis |
|
|
478 | (1) |
|
|
478 | (1) |
|
|
478 | (1) |
|
|
478 | (1) |
|
Systems biology and viruses |
|
|
479 | (2) |
|
|
481 | (3) |
|
|
484 | (1) |
|
Viruses and the Future -- Problems and Promises |
|
|
485 | (16) |
|
Clouds on the horizon -- emerging disease |
|
|
485 | (3) |
|
Sources and causes of emergent virus disease |
|
|
488 | (1) |
|
The threat of bioterrorism |
|
|
489 | (1) |
|
What are the prospects of using medical technology to eliminate specific viral and other infectious diseases? |
|
|
490 | (1) |
|
Silver linings -- viruses as therapeutic agents |
|
|
490 | (1) |
|
Viruses for gene delivery |
|
|
491 | (2) |
|
Using viruses to destroy other viruses |
|
|
493 | (1) |
|
Viruses and nanotechnology |
|
|
493 | (1) |
|
The place of viruses in the biosphere |
|
|
494 | (1) |
|
|
495 | (2) |
|
|
497 | (2) |
|
Additional Reading for Part V |
|
|
499 | (2) |
|
|
501 | (6) |
|
Books of historical and basic value |
|
|
501 | (1) |
|
|
501 | (2) |
|
Molecular biology and biochemistry texts |
|
|
503 | (1) |
|
|
503 | (1) |
|
Sources for experimental protocols |
|
|
503 | (1) |
|
|
504 | (1) |
|
|
504 | (1) |
|
Important websites for organizations and facilities of interest |
|
|
505 | (2) |
Technical Glossary |
|
507 | (26) |
Index |
|
533 | |